Top

AN41--36C24E-21-AP-0340 | 640-21-3-161-0062 | Somalogics

Active

36C24E21Q0143Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Veterans Administration Palo Alto VA Research and Development Group is planning to negotiate a sole source contract with Somalogic to provide specialized services in human protein biomarker discovery for protein profiling in human plasma. This work supports the Million Veteran Program (MVP) under the VA Palo Alto Health Care System and the Veterans Health Administration, aligned with FAR part 8.405-6 as a pilot study. The contract requires that the selected provider have headquarters and laboratory facilities within the Continental United States and demonstrate that their technology can work effectively with human plasma derived from whole blood using EDTA as an anticoagulant. The technology must cover major biological pathways and be capable of large-scale operation, handling tens of thousands of samples annually, with evidence of having measured over 50,000 human samples to date. Additionally, the provider must have the capacity for long-term biospecimen storage in large quantities, possess at least 100 peer-reviewed scientific publications validating their technology, meet platform requirements for profiling more than 1,000 biomarkers with minimal sample usage, and support sample tracking and management via barcode systems to ensure security and traceability. Further criteria include the ability to produce thorough documentation of sample handling and processing to address sample mixing and error tracking, with certification in Good Laboratory Practice (GLP). Although this is not a request for competitive proposals, any capable sources can submit a capability statement by June 11, 2021, with submissions directed exclusively via email to the contracting officer, Elaine DiBucci. The final decision to proceed without competition lies solely with the government. The contract is associated with solicitation number 36C24E21Q0143 and is managed by the Department of Veterans Affairs office in Pittsburgh, Pennsylvania.

General Info

Sole source contract with Somalogic for protein biomarker discovery supporting Million Veteran Program.

Agency

Department Of Veterans Affairs → Rpo East (36C24E)

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Set-Aside

NONE

Documents

VA Special Notice - Somalogics Protein Biomarker Discovery

2 pages · special-notice

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PostedJun 9

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Rpo East (36C24E)

Contacts1 person available

OfficePITTSBURGH, PA, 15212, USA

Organization / AgencyDepartment Of Veterans Affairs → Rpo East (36C24E)

Office AddressPITTSBURGH, PA, 15212, USA

Contacts

Elaine F DiBucciContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

The Veterans Administration Palo Alto VA Research and Development Group intends to negotiate on a sole source basis with Somalogic to provide services related to human protein biomarker discovery for protein profiling in human plasma support the objectives of the VA s Million Veteran Program (MVP), VA Palo Alto Health Care System, Department of Veterans Affairs (VA) Veterans Health Administration (VHA), in accordance with FAR part 8.405-6 as part of a pilot study. In order to meet VA Researcher's needs, the following criteria needs to be met: 1. Headquarters and laboratory facilities where work to be conducted in is located within the Continental United States 2. Evidence that the technology to be used works under human plasma derived from whole blood using EDTA as anticoagulant 3. Evidence that the technology to be deployed covers major biological pathways 4. Laboratory facilities where work will be conducted has the capacity for large-scale measurements in tens of thousands per-year and evidence that have measured >50,000 human samples to date. 5. Capacity for long-term storage of biospecimens in the tens of thousands 6. Evidence of at least 100 scientific per-review publications using the technology to be deployed by the provider 7. Meet Platform requirements of > 1,000 biomarkers with minimal sample consumption (< 150 uL per-platform) 8. Ability for Sample tracking and management utilizing bar coding to ensure security & traceability of VA samples. 9.Ability to produce documentation of sample handling and processing attributes/audit trail, etc. that would address sample mixing and sample error tracking and be certified in Good Laboratory Practice (GLP). This notice of intent is not a request for competitive proposals; however, any responsible source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than Friday, June 11, 2021, 1600, EST. Interest/capability statements may be sent to Elaine DiBucci at contact@example.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.